title: Management of non-necrotizing cellulitis in France.
abstract: OBJECTIVE
  We aimed to assess medical practices of French infectious disease specialists or any other relevant physicians related to the management of non-necrotizing cellulitis (NNC).
  
  
  METHODS
  We sent an online questionnaire to members of the French Infectious Diseases Society (SPILF) mailing list in September 2015.
  
  
  RESULTS
  A total of 108 specialists took part in the survey and 10% (11/107) declared to always admit NNC patients to hospital. As for the others, 18% declared to admit patients in more than 80% of cases, 49% in 50-80% of cases, 26% in 20-50% of cases, and 7% in less than 20% of cases. The most frequent criteria for hospital admission were severe sepsis/septic shock (99%), poor social conditions (99%), rapid extension of skin lesions (93%), high level of pain (86%), and failure of first-line antibiotic therapy (84%). Participants mentioned similar criteria for reasons to initiate the intravenous (IV) antibiotic therapy. Fifty-three percent of respondents declared initiating antibiotic therapy using the IV route in more than 80% of cases. Physicians declared that the usual antibiotic therapy duration were <7 days (6%), 8-10 days (57%), 11-14 days (34%), and >15 days (3%).
  
  
  CONCLUSIONS
  Criteria for hospital admission and use of the IV route for antibiotic therapy as well as optimal treatment duration in patients presenting with NNC need to be detailed in guidelines and evaluated in prospective studies.
authors.affiliation: Service maladies infectieuses, CH de Douai, 59500 Douai, France. Electronic address: xljhe@yahoo.fr.
authors.forename: X
authors.initials: X
authors.lastname: Lemaire
authors.affiliation: Unité mobile d'infectiologie, hôpital J.-Ducuing, 15, rue Varsovie, 31300 Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Bonnet
authors.affiliation: Centre hospitalier d'Ajaccio, 20000 Ajaccio, France.
authors.forename: B
authors.initials: B
authors.lastname: Castan
authors.affiliation: Service de maladies infectieuses et médecine interne, centre hospitalier de Chambéry, 73011 Chambéry cedex, France.
authors.forename: E
authors.initials: E
authors.lastname: Forestier
authors.affiliation: Service de maladies infectieuses et tropicales, hôpital Bichat, AP-HP, Inserm, IAME, UMR 1137, université Paris Diderot, Sorbonne Paris Cité, 75018 Paris, France.
authors.forename: F-X
authors.initials: FX
authors.lastname: Lescure
authors.affiliation: Médecine interne et département de maladies infectieuses, Inserm U1070, université de Poitiers, 86000 Poitiers, France.
authors.forename: F
authors.initials: F
authors.lastname: Roblot
authors.affiliation: Université de Lorraine, université Paris Descartes, EA 4360 APEMAC, 54505 Vandœuvre-lès-Nancy cedex, France; Service de maladies infectieuses et tropicales, hôpitaux de Brabois, CHU de Nancy, 54511 Vandœuvre-lès-Nancy cedex, France.
authors.forename: C
authors.initials: C
authors.lastname: Pulcini
mesh_terms: D000284:Administration, Oral; D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002481:Cellulitis / Q000150:complications / Q000188:drug therapy*; D015897:Comorbidity; D019468:Disease Management; D018450:Disease Progression; D004334:Drug Administration Schedule; D005602:France; D019538:Health Care Surveys; D006760:Hospitalization; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology; D007262:Infusions, Intravenous; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents
keywords: Cellulitis; Dermo-hypodermites bactériennes non nécrosantes; Streptococcus; Streptocoque